Shopping Cart
Remove All
Your shopping cart is currently empty
Citatuzumab bogatox (VB6-845) is a recombinant immunotoxin composed of a humanized antibody's Fab fragment targeting EpCAM and a modified bouganin cytotoxin. It selectively binds to EpCAM-positive cell lines, induces apoptosis, and demonstrates efficacy in EpCAM-positive human tumor xenograft models [1] [2] [3].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Citatuzumab bogatox (VB6-845) is a recombinant immunotoxin composed of a humanized antibody's Fab fragment targeting EpCAM and a modified bouganin cytotoxin. It selectively binds to EpCAM-positive cell lines, induces apoptosis, and demonstrates efficacy in EpCAM-positive human tumor xenograft models [1] [2] [3]. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | EpCAM/TROP1/CD326 |
| Cas No. | 945228-49-9 |
| Storage | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.